{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:38:25Z","timestamp":1776782305721,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00520-023-07820-5","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:35:46Z","timestamp":1686080146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Topical corticosteroids for the prevention of severe radiation dermatitis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"31","author":[{"given":"Samantha","family":"Tam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Trombetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Caini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Ryan Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Beveridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Behroozian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"10","key":"7820_CR1","first-page":"5343","volume":"37","author":"F Haruna","year":"2017","unstructured":"Haruna F, Lipsett A, Marignol L (2017) Topical management of acute radiation dermatitis in breast cancer patients: a systematic review and meta-analysis. Anticancer Res 37(10):5343\u20135353","journal-title":"Anticancer Res"},{"issue":"2","key":"7820_CR2","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jaad.2019.02.047","volume":"81","author":"A Rosenthal","year":"2019","unstructured":"Rosenthal A, Israilevich R, Moy R (2019) Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol 81(2):558\u2013567","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"7820_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/ijd.13371","volume":"56","author":"F Hegedus","year":"2017","unstructured":"Hegedus F, Mathew LM, Schwartz RA (2017) Radiation dermatitis: an overview. Int J Dermatol 56(9):909\u2013914","journal-title":"Int J Dermatol"},{"issue":"1","key":"7820_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","volume":"54","author":"SR Hymes","year":"2006","unstructured":"Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54(1):28\u201346","journal-title":"J Am Acad Dermatol"},{"key":"7820_CR5","doi-asserted-by":"crossref","unstructured":"Hindley A, Zain Z, Wood L, Whitehead A, Sanneh A, Barber D et al (2014) Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 90(4):748\u2013755","DOI":"10.1016\/j.ijrobp.2014.06.033"},{"key":"7820_CR6","doi-asserted-by":"crossref","unstructured":"Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A et al (2018) A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys 101(2):325\u2013333","DOI":"10.1016\/j.ijrobp.2018.02.006"},{"key":"7820_CR7","doi-asserted-by":"crossref","unstructured":"Liao Y, Feng G, Dai T, Long F, Tang J, Pu Y et al (2019) Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas. Medicine (United States) 98(52):e18230","DOI":"10.1097\/MD.0000000000018230"},{"key":"7820_CR8","doi-asserted-by":"crossref","unstructured":"Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC et al (2011) Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys 79(5):1460\u20131466","DOI":"10.1016\/j.ijrobp.2010.01.031"},{"key":"7820_CR9","doi-asserted-by":"crossref","unstructured":"Shaw SZ, Nien HH, Wu CJ, Lui LT, Su JF, Lang CH (2015) 3M Cavilon no-sting barrier film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: a clinical trial. J Formos Med Assoc 114(5):407\u2013414","DOI":"10.1016\/j.jfma.2013.04.003"},{"key":"7820_CR10","doi-asserted-by":"crossref","unstructured":"Menon A, Prem SS, Kumari R (2021) Topical betamethasone valerate as a prophylactic agent to prevent acute radiation dermatitis in head and neck malignancies: a randomized, open-label, phase 3 trial. Int J Radiat Oncol Biol Phys 109(1):151\u2013160","DOI":"10.1016\/j.ijrobp.2020.08.040"},{"key":"7820_CR11","doi-asserted-by":"crossref","unstructured":"Ulff E, Maroti M, Serup J, Falkmer U (2013) A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams. Radiother Oncol 108(2):287\u2013292","DOI":"10.1016\/j.radonc.2013.05.033"},{"key":"7820_CR12","doi-asserted-by":"crossref","unstructured":"Omidvari S, Saboori H, Mohammadianpanah M, Mosalaei A, Ahmadloo N, Mosleh-Shirazi MA et al (2007) Topical betamethasone for prevention of radiation dermatitis. Indian Journal of Dermatology, Venereology and Leprology 73(3):209","DOI":"10.4103\/0378-6323.32755"},{"key":"7820_CR13","doi-asserted-by":"crossref","unstructured":"Ulff E, Maroti M, Serup J, Nilsson M, Falkmer U (2017) Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: a randomized double blinded study. Radiother Oncol 122(1):50\u201353","DOI":"10.1016\/j.radonc.2016.11.013"},{"key":"7820_CR14","doi-asserted-by":"crossref","unstructured":"Bostr\u00f6m \u00c5, Lindman H, Swartling C, Berne B, Bergh J (2001) Potent corticosteroid cream [mometasone furoate] significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol 59(3):257\u2013265","DOI":"10.1016\/S0167-8140(01)00327-9"},{"key":"7820_CR15","doi-asserted-by":"crossref","unstructured":"Wright JL, Takita C, Reis IM, Zhao W, Lee E, Hu JJ (2014) Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation. Int J Radiat Oncol Biol Phys 90(2):335\u2013343","DOI":"10.1016\/j.ijrobp.2014.06.042"},{"issue":"2","key":"7820_CR16","first-page":"299","volume":"26","author":"M Gieringer","year":"2011","unstructured":"Gieringer M, Gosepath J, Naim R (2011) Radiotherapy and wound healing: Principles, management and prospects [review]. Oncol Rep 26(2):299\u2013307","journal-title":"Oncol Rep"},{"issue":"6","key":"7820_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1586\/17512433.2013.841079","volume":"6","author":"CF Meghrajani","year":"2013","unstructured":"Meghrajani CF, Co HC, Ang-Tiu CM, Roa FC (2013) Topical corticosteroid therapy for the prevention of acute radiation dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol 6(6):641\u2013649","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"10","key":"7820_CR18","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00520-013-1896-2","volume":"21","author":"RKS Wong","year":"2013","unstructured":"Wong RKS, Bensadoun RJ, Boers-Doets CB, Bryce J, Chan A, Epstein JB et al (2013) Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Supportive Care Cancer 21(10):2933\u201348","journal-title":"Supportive Care Cancer"},{"key":"7820_CR19","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 9782, Betamethasone. PubChem [Internet]. 2022 [cited 2022 Mar 26]; Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Betamethasone"},{"key":"7820_CR20","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 441335, Mometasone. Pubchem [Internet]. 2022 [cited 2022 Mar 26]; Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Itaconic-acid"},{"issue":"1","key":"7820_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9(1):1\u201325","journal-title":"Allergy Asthma Clin Immunol"},{"key":"7820_CR22","doi-asserted-by":"crossref","unstructured":"Naylor W, Mallett J (2001) Management of acute radiotherapy induced skin reactions: a literature review. Eur J Oncol Nurs 5(4):221\u2013233","DOI":"10.1054\/ejon.2001.0145"},{"key":"7820_CR23","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906","journal-title":"Int J Surg"},{"key":"7820_CR24","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"7820_CR25","doi-asserted-by":"crossref","unstructured":"Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49(7):749\u2013754","DOI":"10.1016\/0895-4356(96)00019-4"},{"key":"7820_CR26","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz JA, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group [RTOG] and the European organization for research and treatment of cancer [EORTC]. Int J Radiat Oncol Biol Phys 31:1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7820_CR27","doi-asserted-by":"crossref","unstructured":"Colevas AD, Setser A (2004) The NCI common terminology criteria for adverse events [CTCAE] v 3.0 is the new standard for oncology clinical trials. J Clin Oncol 22(14_suppl)","DOI":"10.1200\/jco.2004.22.90140.6098"},{"key":"7820_CR28","first-page":"e15918","volume":"10","author":"X Shao","year":"2022","unstructured":"Shao X, Chen T, Li H, Chen Y, Zhang Y, Chen J, Li Y, Liu L, Pu Y, Chen J (2022) Efficacy of topical steroids in preventing radiation dermatitis: a systematic review and meta-analysis. Dermatol Ther 10:e15918","journal-title":"Dermatol Ther"},{"issue":"3","key":"7820_CR29","first-page":"268","volume":"2","author":"VK Wong","year":"2003","unstructured":"Wong VK, Della Croce C, Schonfeld S, Mastrangelo AM, Lebwohl M (2003) Use and abuse of topical corticosteroids in infections of the skin and related structures. J Drugs Dermatol: JDD 2(3):268\u2013276","journal-title":"J Drugs Dermatol: JDD"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07820-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:05:50Z","timestamp":1689329150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["7820"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07820-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"382"}}